Associate Director - Operational Readiness (NOT REMOTE - NEW SITE)

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree in a STEM discipline and have experience in a functional or operational leadership role within the pharmaceutical industry. A minimum of 5 years of experience supporting GMP operations is required, along with proven experience leading large, cross-functional projects from initiation to successful delivery and proficiency in continuous improvement methodologies like Lean or Six Sigma.

Responsibilities

The Associate Director of Operational Readiness is responsible for developing and managing an integrated project plan to prepare a new manufacturing facility for operational readiness. This role involves collaborating with cross-functional teams, serving as the primary liaison between project teams and site functions, leading a team to implement the plan, and ensuring clear communication and aligned priorities. The position also requires driving timely decision-making, managing stakeholder relationships, resolving issues, forecasting resource needs, reporting key metrics, and building a culture of operational excellence by embedding Lean principles.

Skills

Operational Readiness

Project Management

Lean Principles

Continuous Improvement

GMP Manufacturing

API Manufacturing

Stakeholder Management

Cross-functional Collaboration

Site Startup

Leadership

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free